According to a complaint filed in a federal court in Massachusetts, Novartis Pharmaceutical Corp. conspired to improperly withhold generic versions of Gleevec — a blockbuster leukemia medication — from the consumer market.

Continue reading “Novartis named in pay for delay class action involving Gleevec”